Kerna

Kerna Labs develops machine learning models to create and optimize genetic medicines. It utilizes foundational RNA models, designing therapeutically enhanced mRNA sequences. The platform integrates computational methods to engineer biological molecules, accelerating discovery and improving novel therapy development.

Founded by biotech veterans Julia Peng (CEO), Amit Deshwar (Co-founder & CTO), and Melissa J. Moore (Co-founder), Kerna Labs originated from an insight combining AI with mRNA technology. Deshwar (ex-SVP, Deep Genomics) and Moore (ex-CSO, Moderna) brought significant expertise in AI-driven sequence design and mRNA therapeutics.

Kerna Labs targets pharmaceutical and biotechnology sectors, offering a platform for next-generation genetic medicines. Its vision centers on leveraging artificial intelligence to reshape RNA therapeutics, enabling safer, more effective treatments. The goal is to unlock new therapeutic possibilities in genetic medicine.